Comme l’an dernier, Accor s’est positionné parmi les premiers émetteurs à faire sa rentrée sur le marché obligataire. Fin août, le groupe a ainsi émis une nouvelle souche de 500 m EUR à 7 ans, qui sera utilisée pour rembourser la prochaine tombée début 2026. Nous profitons de l’occasion pour refaire un point sur la signature et ajuster nos recommandations. Nous conservons un Avis Crédit Stable sur Accor. La page du covid étant tournée depuis longtemps, Accor a retrouvé des niveaux d’endettement ...
Like last year, Accor was among the first issuers to tap the bond market after the summer break. Late August, the group issued a new € 500m seven-year bond, which will be used to meet the next bond repayment due in early 2026. We avail ourselves of this opportunity to review the issuer and fine-tune our recommendations on the bonds. We reiterate our Stable credit opinion on the issuer. Now that the covid crisis is long behind it, Accor's debt has moved back to levels consistent with its financi...
A director at Accor sold 86,000 shares at 41.022EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing ...
A director at Whitbread Plc sold 1,000 shares at 3,173p and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...
2Q'25 vs. 2Q'24 Results Sales: € 545.5 M (+4.9% vs. +3.8% BS(e) and +3.6% consensus); EBITDA: € 152.6 M (+7.2% vs. +3.7% BS(e) and +2.7% consensus); 1H'25 vs. 1H'24 Results Sales: € 986.6 M (+3.0% vs. +2.4% BS(e) and +2.4% consensus); EBITDA: € 243.6 M (+2.5% vs. +0.4% BS(e) and -0.2% consensus);
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.